Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma
Yunxiu Luo,1,* Xiaopeng Huang,2,* Jiabin Zhan,3 Shuai Zhang2 1Department of Radiation Oncology, Hainan Cancer Hospital, Affiliated Cancer Hospital of Hainan Medical University, Haikou, 570311, Hainan Province, People’s Republic of China; 2Department of Radiation Oncology, Hainan Gene...
Guardado en:
Autores principales: | Luo Y, Huang X, Zhan J, Zhang S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a434fed3b60b491480c03dab9c98d34c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Efficacy and Prognostic Factors of the Combination of TACE and Apatinib for the Treatment of BCLC Stage C Hepatocellular Carcinoma
por: Shun Liu, et al.
Publicado: (2021) -
A Novel Pyroptosis-related Prognostic Model for Hepatocellular Carcinoma
por: Qianqian Wu, et al.
Publicado: (2021) -
SRD5A3-CDG: Emerging Phenotypic Features of an Ultrarare CDG Subtype
por: Nazreen Kamarus Jaman, et al.
Publicado: (2021) -
Biejiajian Pill Promotes the Infiltration of CD8+ T Cells in Hepatocellular Carcinoma by Regulating the Expression of CCL5
por: Xuemei Yang, et al.
Publicado: (2021) -
Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Yumei Fan, et al.
Publicado: (2021)